These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 20398718

  • 1. Interactions between specific parameters of cannabis use and verbal memory.
    Wagner D, Becker B, Gouzoulis-Mayfrank E, Daumann J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug 16; 34(6):871-6. PubMed ID: 20398718
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.
    J Psychopharmacol; 2006 May 16; 20(3):373-84. PubMed ID: 16574711
    [Abstract] [Full Text] [Related]

  • 6. Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users.
    Jacobsen LK, Pugh KR, Constable RT, Westerveld M, Mencl WE.
    Biol Psychiatry; 2007 Jan 01; 61(1):31-40. PubMed ID: 16631130
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Executive function deficits in short-term abstinent cannabis users.
    McHale S, Hunt N.
    Hum Psychopharmacol; 2008 Jul 01; 23(5):409-15. PubMed ID: 18421794
    [Abstract] [Full Text] [Related]

  • 9. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G, Redman J.
    Psychol Med; 2008 Sep 01; 38(9):1319-30. PubMed ID: 18226286
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neurocognitive consequences of marihuana--a comparison with pre-drug performance.
    Fried PA, Watkinson B, Gray R.
    Neurotoxicol Teratol; 2005 Sep 01; 27(2):231-9. PubMed ID: 15734274
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA, Vaskinn A, Sundet K, Engh JA, Jónsdóttir H, Simonsen C, Friis S, Opjordsmoen S, Melle I, Andreassen OA.
    Psychol Med; 2010 Aug 01; 40(8):1337-47. PubMed ID: 19891810
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH.
    Aust N Z J Psychiatry; 2010 Mar 01; 44(3):230-6. PubMed ID: 20180725
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The impact of early-onset cannabis use on functional brain correlates of working memory.
    Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug 16; 34(6):837-45. PubMed ID: 20363277
    [Abstract] [Full Text] [Related]

  • 19. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul 16; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.